Editing Medication (section)

===Canada===
In Canada, the Patented Medicine Prices Review Board examines drug pricing and determines if a price is excessive or not. In these circumstances, drug manufacturers must submit a proposed price to the appropriate regulatory agency. Furthermore, "the International Therapeutic Class Comparison Test is responsible for comparing the National Average Transaction Price of the patented drug product under review"<ref name=price-comparison>{{cite web|title=Schedule 7 – International Therapeutic Class Comparison Test|url=http://www.pmprb-cepmb.gc.ca/view.asp?ccid=492&lang=en|date=30 April 2014|access-date=16 March 2017|archive-date=17 April 2018|archive-url=https://web.archive.org/web/20180417225251/http://www.pmprb-cepmb.gc.ca/view.asp?ccid=492&lang=en|url-status=live}}</ref> different countries that the prices are being compared to are the following: France, Germany, Italy, Sweden, Switzerland, the United Kingdom, and the United States<ref name=price-comparison />